XML 13 R2.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 187,026 $ 69,485
Investments in marketable securities 143,325 144,548
Accounts receivable 1,304  
Inventories 3,416 0
Prepaid expenses and other current assets 4,993 2,568
Total current assets 340,064 216,601
Property and equipment, less accumulated depreciation of $12,495 and $13,353 at December 31, 2016 and 2015, respectively 9,816 6,178
In-process research & development 486,700 486,700
Goodwill 197,797 197,797
Other non-current assets 2,468 1,108
Total Assets 1,036,845 908,384
Current liabilities:    
Accounts payable, accrued expenses , and other current liabilities 41,008 32,216
Deferred reimbursements, current portion 13,850  
Contingent consideration payable, current portion 56,101 41,400
Total current liabilities 110,959 73,616
Deferred reimbursements 21,906 35,756
Convertible notes 154,464  
Due to related party   41,601
Contingent consideration payable 213,621 232,677
Deferred income taxes 173,771 176,219
Other non-current liability 1,973 681
Commitments and contingencies
Stockholders' equity:    
Common stock, $.01 par value, 250,000,000 shares authorized, 142,691,986 shares issued and outstanding at December 31, 2016 Common stock, $.01 par value, 250,000,000 shares authorized, 125,027,034 shares issued and outstanding at December 31, 2015 1,480 1,306
Additional paid-in capital 1,120,156 917,454
Accumulated other comprehensive loss:    
Foreign currency translation adjustment, less tax benefit of $1,293 at December 31, 2016 1,945  
Unrealized gain/(loss) on available-for securities 102 (115)
Warrants 16,076 8,755
Accumulated deficit (779,608) (579,566)
Total stockholders' equity 360,151 347,834
Total Liabilities and Stockholders' Equity $ 1,036,845 $ 908,384